HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmetics labeling harmonization within EU remains "key" COLIPA objective.

This article was originally published in The Rose Sheet

Executive Summary

COSMETICS LABELING HARMONIZATION WITHIN EU REMAINS "KEY" COLIPA OBJECTIVE due to the issue's "growth in importance in the last year or two," newly elected European Cosmetic, Toiletry and Perfumery Association (COLIPA) Secretary General Alan McGee said at the trade group's annual Information Day in Brussels Feb. 4. COLIPA will continue to work with European Union member states to "try and facilitate the marketing" of cosmetics products with labeling using the International Cosmetic Ingredient Nomenclature (INCI), he said. These continuing efforts are aimed at providing a "global marketing...approach" for union members as well as the 10 new countries expected to join the EU between 2001 and 2003, McGee explained. The harmonization issue will be the main topic of discussion at a COLIPA regulatory conference in April in Florence, Italy.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel